posted on 2019-04-29, 00:00authored byHong Jia, Guangxiu Dai, Weiguo Su, Kun Xiao, Jianyang Weng, Zhulin Zhang, Qing Wang, Tianhai Yuan, Fuying Shi, Zheng Zhang, Wei Chen, Yang Sai, Jian Wang, Xiong Li, Yu Cai, Jun Yu, Ping Ren, Jennifer Venable, Tadimeti Rao, James P. Edwards, Scott D. Bembenek
An electronic density model was developed
and used to identify
a novel pyrrolotriazinone replacement for a quinazolinone, a commonly
used moiety to impart selectivity in inhibitors for PI3Kγ and
PI3Kδ. Guided by molecular docking, this new specificity piece
was then linked to the hinge-binding region of the inhibitor using
a novel cyclic moiety. Further structure–activity relationship
optimization around the hinge region led to the discovery of candidate 26, a highly potent and selective PI3Kγ–PI3Kδ
dual inhibitor with favorable drug metabolism and pharmacokinetic
properties in preclinical species.